Reaction
Campylobacter Infection reporting signals
As of the last recalculation, Campylobacter Infection appears in 823 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is BENDAMUSTINE HCL (PRR 59.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bendamustine Hcl | 35 | 59.6 | 59.7 |
| Fludarabine Phosphate | 55 | 37.8 | 37.9 |
| Anti-Thymocyte Globulin (Rabbit) | 11 | 34.9 | 35.0 |
| Ganciclovir | 11 | 27.5 | 27.6 |
| Ganciclovir Sodium | 11 | 26.6 | 26.7 |
| Meperidine Hydrochloride | 9 | 25.0 | 25.0 |
| Thiotepa | 9 | 24.1 | 24.1 |
| Sirolimus | 12 | 22.8 | 22.9 |
| Vedolizumab | 63 | 19.9 | 20.0 |
| Rotigotine | 11 | 19.5 | 19.5 |
| Valganciclovir Hydrochloride Powder, | 8 | 16.7 | 16.8 |
| Busulfan | 10 | 16.3 | 16.3 |
| Axicabtagene Ciloleucel | 6 | 15.5 | 15.5 |
| Pegaspargase | 7 | 14.6 | 14.6 |
| Ofatumumab | 18 | 14.0 | 14.0 |
| Obinutuzumab | 9 | 14.0 | 14.0 |
| Ibrutinib | 41 | 13.5 | 13.5 |
| Polatuzumab Vedotin | 5 | 13.0 | 13.0 |
| Teduglutide | 6 | 11.3 | 11.3 |
| Deferasirox | 11 | 10.6 | 10.6 |
| Irinotecan Hydrochloride | 5 | 9.9 | 9.9 |
| Temozolomide | 7 | 8.5 | 8.5 |